Mirae Asset Global Investments Co. Ltd. reduced its position in HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 13.2% in the first quarter, Holdings Channel.com reports. The fund owned 202,548 shares of the company's stock after selling 30,747 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in HealthEquity were worth $13,660,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Signaturefd LLC boosted its position in shares of HealthEquity by 44.3% in the first quarter. Signaturefd LLC now owns 954 shares of the company's stock valued at $64,000 after acquiring an additional 293 shares during the period. Clearstead Advisors LLC bought a new position in shares of HealthEquity in the first quarter valued at approximately $65,000. Captrust Financial Advisors lifted its position in HealthEquity by 92.5% during the first quarter. Captrust Financial Advisors now owns 1,176 shares of the company's stock valued at $79,000 after purchasing an additional 565 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its position in HealthEquity by 30.0% during the first quarter. Steward Partners Investment Advisory LLC now owns 1,371 shares of the company's stock valued at $92,000 after purchasing an additional 316 shares during the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new stake in HealthEquity during the fourth quarter valued at approximately $68,000. 99.43% of the stock is currently owned by institutional investors.
Get
HealthEquity alerts:
HealthEquity Stock Up 0.7 %
Shares of NASDAQ HQY opened at $71.88 on Tuesday. HealthEquity, Inc. has a 52 week low of $36.81 and a 52 week high of $73.29. The firm's fifty day moving average is $62.21 and its 200 day moving average is $62.51. The company has a market cap of $6.08 billion, a price-to-earnings ratio of -97.14, a PEG ratio of 4.25 and a beta of 0.90.
HealthEquity (NASDAQ:HQY – Get Rating) last issued its earnings results on Tuesday, September 6th. The company reported $0.33 EPS for the quarter, hitting the consensus estimate of $0.33. HealthEquity had a negative net
margin of 7.82% and a positive return on equity of 2.86%. During the same period in the prior year, the business earned $0.21 EPS. Equities research analysts anticipate that HealthEquity, Inc. will post 0.69 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the stock. SVB Leerink lifted their target price on shares of HealthEquity from $67.00 to $76.00 and gave the company an "outperform" rating in a research report on Tuesday, June 7th. Wells Fargo & Company lifted their target price on shares of HealthEquity from $95.00 to $100.00 and gave the company an "overweight" rating in a research report on Tuesday, September 13th. Robert W. Baird lifted their target price on shares of HealthEquity from $47.00 to $67.00 and gave the company a "neutral" rating in a research report on Wednesday, September 7th. KeyCorp assumed coverage on shares of HealthEquity in a research report on Thursday, September 15th. They set an "overweight" rating and a $85.00 target price for the company. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research note on Tuesday, July 12th. They set a "sell" rating and a $59.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the stock. According to MarketBeat, HealthEquity has a consensus rating of "Moderate Buy" and an average price target of $75.36.
Insider Buying and Selling
In other HealthEquity news, COO Edward Bloomberg sold 1,000 shares of the business's stock in a transaction on Monday, August 1st. The shares were sold at an average price of $57.63, for a total transaction of $57,630.00. Following the transaction, the chief operating officer now directly owns 59,850 shares of the company's stock, valued at approximately $3,449,155.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 2.80% of the stock is owned by insiders.
About HealthEquity
(Get Rating)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Read More
- Get a free copy of the StockNews.com research report on HealthEquity (HQY)
- Oracle's Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin' It: Investors Keep Visiting McDonald's
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Get Rating).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
